Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 629 clinical trials
COVID-19 Staff Testing of Antibody Responses Study (Co-Stars)

Within this cohort, a subset of 150-250 staff members with confirmed (PCR positive) SARS-CoV-2 disease will be followed with intensive monthly testing for 6 months to determine whether antibody levels in the blood are maintained or decrease during this time. All 1000 recruited healthcare workers will be followed 6-monthly

acute respiratory syndrome (sars)
blood test
cough
covid-19
SARS
  • 0 views
  • 05 Aug, 2020
Epidemiologic Clinical Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection

The study cohort will be enrolled among all Humanitas group employees (including ICH, Humanitas University and Gavazzeni), and two validation cohorts. Participants will be asked consent for the research use of blood, pharyngeal swab, and for those hospitalized for COVID-19, also for the bronchoalveolar lavage and fecal samples.

bronchoalveolar lavage
covid-19
  • 0 views
  • 16 Feb, 2024
  • 1 location
HeartStart FRx Defibrillator Event Registry

This registry has several safeguards in place to prevent against selections bias, including enrollment of all participants who have pads placed. This registry will evaluate the safety and verify the clinical performance of the device in relation to its claims, when used in accordance with the Device Manual.

circulatory arrest
shock
defibrillation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Pancreatic adenocarcinoma will be the 2nd cause of death by cancer in Europe in 2030. Pancreatic adenocarcinoma has poor prognosis with an all-stages combined 5-year survival rate below 8%. Since December 2019, a new coronavirus (Severe Acute Respiratory Syndrome Corona Virus 2, SARS-CoV-2) is responsible of COVID-19 infection with potentially …

pancreatic adenocarcinoma
adenocarcinoma
pancreatic cancer
diagnostic procedure
acute respiratory syndrome (sars)
  • 0 views
  • 16 Feb, 2024
  • 1 location
Prediction of Clinical Course in COVID19 Patients

Deconfinement and its consequences will complicate the triage of COVID patients and the role of the scanner, with the expected impact of a decrease in the prevalence of infection in the emergency department and an increase in the number of "all-round" patients, including patients with non-COVID viral infiltrates or pneumopathies. …

PCR test
chest ct
ct scan
lung disease
pneumonia
  • 0 views
  • 05 Aug, 2020
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

Gaucher Pregnancy Sub-registry: The primary objective of this Sub-registry is to track pregnancy outcomes, including complications and infant growth, in all women with Gaucher disease during pregnancy, regardless of whether they receive disease-specific therapy. No experimental intervention is given; thus a patient will undergo clinical assessments and receive standard of …

deficiency
imiglucerase
eliglustat
gaucher disease
  • 0 views
  • 04 Dec, 2020
  • 209 locations
Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments

Healthcare renunciation is defined as: "Individuals give up care when they do not seek services and health care professionals when they experience a disorder, experience a physical or mental disorder, or when they do not access all of the prescribed care." In 2008, 16.5% of the general French population reported …

  • 0 views
  • 16 Feb, 2024
  • 2 locations
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)

The GENVASC study capitalises on the unique opportunity provided by the NHS Health Check Programme, which is being widely promoted and specifically targets all individuals aged 40-74 years who are free of cardiovascular disease. Consenting participants taking part in the health check programme are asked to provide an additional sample …

coronary disease
arteriopathy
cardiovascular disease
  • 0 views
  • 16 Feb, 2024
  • 1 location
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

muscle rigidity
modafinil
genetic testing
tremor
bradykinesia
  • 0 views
  • 16 Feb, 2024
  • 46 locations
Association of Inpatient Blood Pressure Levels With In-hospital Adverse Events(APPLE Study)

The purpose of the study is to investigate the association between inpatient blood pressure levels and in-hosopital adverse outcomes.

  • 0 views
  • 16 Feb, 2024
  • 1 location